UBS starting to get pretty positive about our stock with an upgrade and a $295 target.
- Forums
- ASX - By Stock
- CSL has more upside...
UBS starting to get pretty positive about our stock with an...
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$283.91 |
Change
-2.750(0.96%) |
Mkt cap ! $137.3B |
Open | High | Low | Value | Volume |
$285.50 | $285.81 | $282.18 | $45.35M | 159.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8 | $283.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$283.95 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 24 | 283.940 |
2 | 12 | 283.920 |
1 | 25 | 283.910 |
1 | 8 | 283.900 |
1 | 25 | 283.870 |
Price($) | Vol. | No. |
---|---|---|
283.970 | 28 | 1 |
283.980 | 9 | 1 |
283.990 | 44 | 3 |
284.000 | 25 | 1 |
284.010 | 54 | 6 |
Last trade - 14.42pm 13/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online